CTSL/CAPN1-IN-2

• CAS Number:

  2410075-64-6

• UNSPSC Description:

  CTSL/CAPN1-IN-2 (Compound 14b) is an orally active inhibitor of both CTSL and CAPN1, with IC50 values of 6.88 nM and 347.6 nM, respectively. CTSL/CAPN1-IN-2 possesses anti-inflammatory properties and favorable pharmacokinetic characteristics. CTSL/CAPN1-IN-2 exhibits broad-spectrum antiviral activity against coronaviruses by blocking viral entry[1].

• Target Antigen:

  Cathepsin; SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection;Metabolic Enzyme/Protease

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ctsl-capn1-in-2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC2=CC=CC=C2O1)N[C@@H](CC3CCCCC3)C(N[C@H](C(C(NCC4=CC=CC=C4)=O)=O)C[C@H]5C(NCCC5)=O)=O

• Molecular Weight:

  600.70

• References & Citations:

  [1]Xie X, et al. Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal Transduct Target Ther. 2024 Mar 6;9(1):54.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported